Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-7,922
Closed -$413K 1551
2025
Q2
$413K Buy
+7,922
New +$435K 0.02% 632
2024
Q1
Sell
-6,096
Closed -$668K 1503
2023
Q4
$668K Buy
+6,096
New +$630K 0.05% 304
2023
Q3
Sell
-3,023
Closed -$411K 1388
2023
Q2
$411K Buy
+3,023
New +$369K 0.03% 467
2021
Q3
Sell
-1,686
Closed -$232K 1565
2021
Q2
$232K Sell
1,686
-699
-29% -$95.7K 0.02% 888
2021
Q1
$311K Buy
+2,385
New +$287K 0.02% 794
2019
Q3
Sell
-6,633
Closed -$568K 1471
2019
Q2
$568K Buy
+6,633
New +$545K 0.03% 482
2018
Q4
Sell
-5,206
Closed -$412K 1609
2018
Q3
$412K Buy
+5,206
New +$403K 0.03% 685

Other funds holding CNMD

Virtu Financial's CNMD Position: Q3 2025 in Review

Virtu Financial sold out of CONMED (CNMD) in Q3 2025, closing a stake of 7,922 shares — an estimated $413K sold.

Virtu Financial first reported a position in CNMD in Q3 2018 and held it in 7 quarters. The position peaked at $668K in Q4 2023. 273 funds tracked by Wall St. Rank hold CNMD as of Q3 2025.

  • Virtu Financial reported no remaining CONMED position as of Q3 2025 after selling out during the quarter.
  • Virtu Financial sold 7,922 CONMED shares in Q3 2025, an estimated $413K.
  • Virtu Financial first reported a position in CONMED in Q3 2018 and held it in 7 quarters.
  • Virtu Financial's CONMED position peaked at $668K in Q4 2023.
  • 273 funds tracked by Wall St. Rank held CONMED as of Q3 2025.

Based on Virtu Financial's 13F filing for Q3 2025, filed 14 Nov 2025.